지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology
2019 .01
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2018 .01
Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]
Clinical and Molecular Hepatology
2022 .10
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
Clinical and Molecular Hepatology
2018 .01
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
Clinical and Molecular Hepatology
2021 .10
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2021 .01
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Clinical and Molecular Hepatology
2020 .01
Is the Prevalence of Chronic Hepatitis B Really Increasing in Korea?
Journal of Korean Medical Science
2024 .01
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Clinical and Molecular Hepatology
2020 .01
Current and future strategies for the treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2021 .01
Chronic Hepatitis C Virus Infection, Why Not Treat Now?
대한류마티스학회지
2018 .01
A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B
Clinical and Molecular Hepatology
2020 .01
만성 B형간염 치료의 최신 지견: 2018 대한간학회 진료 가이드라인을 중심으로
대한내과학회지
2019 .06
Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Clinical and Molecular Hepatology
2018 .01
Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
Gut and Liver
2023 .03
Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?
Clinical and Molecular Hepatology
2020 .01
Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study
Journal of Korean Medical Science
2018 .01
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
Clinical and Molecular Hepatology
2024 .04
Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
Clinical and Molecular Hepatology
2023 .04
Evaluation of the acute hepatitis B surveillance system in the Republic of Korea following the transition to mandatory surveillance
Osong Public Health and Research Persptectives
2024 .08
0